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Metabolic engineering was originally conceived as a sys-
tems approach to optimise biotechnologically desired
traits of microbes and higher cells [1]. Microbial Cell Facto-
ries has published several review and research articles on
this field over the past recent years [2-8]. Although clear
breakthroughs have been achieved in the past, progress in
metabolic engineering has been largely limited to individ-
ual pathways or relatively simple networks. Engineering
of complex metabolic networks has been hampered by
the insufficient biological information and global analyt-
ical tools.
Systems biology is increasingly generating a quantitative
knowledge base of cell physiology, offering, for the first
time, insights into molecular/cellular processes and func-
tion at a cell-wide scale. In order for metabolic/cellular
engineers to embrace the potential that systems biology
offers, an understanding of a variety of analytical and
mathematical/computational tools is required [9-12].
However, whilst our knowledge on the systems compo-
nents (genes, proteins, metabolites) has increased signifi-
cantly, data integration in computer models with
appropriate mechanistic and molecular detail to enable in
silico experiments of sufficient predictive capability is still
limiting the increase in the success rate of microbial cell
factories engineering strategies.
Microbial Cell Factories is already contributing to individ-
ual systems biology-driven technological and methodo-
logical advances, experimental (at the transcriptomic [13-
15], proteomic [16] and metabolomic/fluoxomic levels
[17-20]) or computational [21,22]. Whilst strengthening
this trend, we would also like to expand our field of inter-
est to the integration of experimental data with computa-
tional and theoretical methods by encouraging the
publication of research and review articles covering core
aspects of the application of systems biology to the engi-
neering of microbial cell factories (i.e. metabolic or cellu-
lar engineering). Moreover, the growing number of host
cell systems being explored as factories, the continuous
improvement of genetic tools, progress in de novo synthe-
sis of increasingly complex biological entities (synthetic
biology [23]) and, the growing diversity of bioproducts, is
creating an emerging interest to extend our knowledge
base to cell factories other than the classic model organ-
isms. Also, a comparative analysis amongst different
organisms is expected to yield new insights in cellular
processes and function.
While of general interest in the green and white biotech-
nology, we believe our initiative will also contribute to
fulfil the changing needs within highly specialized techni-
cal and scientific areas in biomedicine and biotechnology.
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